genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Gene Therapy
Laying the Foundation for CF Therapy: An Interview with Michael Boyle
Coronavirus
Beyond the Spike: The COVAXX Approach to a COVID-19 Vaccine
Bioprocessing
Cytiva Plans $500M Expansion, 1,000 New Hires Worldwide
Coronavirus
A ‘Human’ Touch vs. COVID-19
Gene Therapy
AGTC Sets Sights on Late-Stage Retinitis Pigmentosa Gene Therapy Trial
News
Coronavirus
J&J’s Janssen Launches Up-to-60,000-Patient Phase III Trial for COVID-19 Vaccine
Coronavirus
Closer Look at SARS-CoV-2 Protein Glycans Points to New Therapeutic and…
3D Printing
3D Printed Kidneys Included in CollPlant and United Therapeutics’ Expanded Collaboration
Imaging analysis
Cellular Force Visible at Molecular Scale Using PAINT Imaging
Antibodies
Lupus Patients Treated Successfully with mAb Targeting Plasma Cells
Insights
All
Trends for 2020
A-Lists
Top 50 NIH-Funded Institutions of 2020
Bioprocessing
Genetic Engineering Across the Tree of Life
Coronavirus
Controversy Aside, Why the Source of COVID-19 Matters
Bioprocessing
Sensors Take on Undersampling in Biomanfacturing
A-Lists
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Upcoming Webinars
The Life and Times of Rosalind Franklin
Coronavirus
J&J’s Janssen Launches Up-to-60,000-Patient Phase III Trial for COVID-19 Vaccine
3D Printing
3D Printed Kidneys Included in CollPlant and United Therapeutics’ Expanded Collaboration
Antibodies
Lupus Patients Treated Successfully with mAb Targeting Plasma Cells
Magazine
All
Supplement
September 2020 Vol. 40 No. 9
Cold Cases Heat Up with New Forensic DNA Methods
September 2020 Vol. 40 No. 9
CRISPR Value Chains Support New Therapeutic Strategies
September 2020 Vol. 40 No. 9
Nonviral CRISPR Delivery Vehicles Lay the Smart Siege
Point of View
Multimodal Screening—The Future of Drug Discovery and Development
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Antibodies
Bispecific Antibodies
Bispecific Antibodies
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Bispecific Antibodies
AbCellera’s CEO: Flattening the Curve of Technology Development
Bispecific Antibodies
Genmab Partners on Cancer Antibodies with BliNK Biomedical, Launches $503M U.S. IPO
Bispecific Antibodies
Recent Advances and the Future of Antibody Engineering
Bispecific Antibodies
AbbVie to Co-Develop Teneobio’s Lead Candidate for Multiple Myeloma, Gains Acquisition Option
Bispecific Antibodies
Sanofi to Develop Biomunex Bi-, Multi-Specific Antibodies for Immuno-Oncology and Other Areas
Bispecific Antibodies
Bispecific Playgrounds? No, Factory Floors
Bispecific Antibodies
Bispecific Antibodies Grapple with Cancer by Grabbing T Cells
Bispecific Antibodies
Daiichi Sankyo Triples Down on Immuno-Oncology Collaboration with Zymeworks
Bispecific Antibodies
Janssen to Develop Bispecific Antibodies Based on Zymeworks Platforms in Up-to-$1.4B...
Bispecific Antibodies
Bifunctional Antifungal Besets the Cell Wall, Rallies Antibodies to the Siege
Bispecific Antibodies
Celgene Ends Option to Buy Sutro, Gains Rights to I/O Candidates...
Bispecific Antibodies
Alligator, Aptevo Partner on Bispecific Cancer Immunotherapy Targeting 4-1BB
Bispecific Antibodies
F-star, Merck Agree Up to €1B Deal to Develop Five Bispecific...
Bispecific Antibodies
EpimAb Raises $25M in Series A to Progress Bispecific Antibodies into...
Bispecific Antibodies
Hanmi, Innovent Agree to Co-Develop Bispecific Anticancer Antibody
Load more
Scroll Up
Please share your location to continue
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![The structure of the ROR1-binding arm of the bispecific antibody in complex with ROR1 was determined by X-ray crystallography. [Rader lab/The Scripps Research Institute]](https://www.genengnews.com/wp-content/uploads/2018/08/May31_2018_RaderLadScrippsInst_AntibodyBindingSite4715364246-324x160.jpg "Bispecific Antibodies Grapple with Cancer by Grabbing T Cells")
